Figure 3.

LOXL1‐AS1 promoted the maintenance of CSC characteristics in gastric carcinoma. A, The sphere formation assay was adopted to evaluate the effects of LOXL1‐AS1 depletion on sphere‐forming ability. B, The diameter and quantity of spheres when LOXL1‐AS1 was overexpressed in AGS cells. C, Western blot results of the expression of stem markers (Nanog, SOX2, OCT4) in transfected MKN‐45 and AGS cells. D, CCK8 assay was utilized to assess cell viability after treatment with different doses of cisplatin. ^* P < .05, ^** P < .01